Floatz logo

Lamivudine

HIV Cardiomyopathy

Thomas BenfieldSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the HIV Cardiomyopathy cohort.

Asset / SponsorPhaseRating
Dolutegravir
Thomas Benfield
Phase 4BB

Same molecule, other indications

Lamivudine is also rated in:

lipodystrophyDormant
BBB
Indicative ·
78 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
chronic hepatitis B virus infectionDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →